Moreover, elevated PKCι level increases resistance to cisplatin in glioblastoma cells by suppressing GMFβ/p38 MAPK signaling [85] and induces glioblastoma motility by coordinating the formation of a single leading-edge lamellipod [81]. The gene discussed is PRKCA; the disease is glioblastoma.